Business Type: Manufacturer, Trading Company Verified
Location: Shandong, China (Mainland) Verified
Main Products: Human Menopausal Gonadotrophin,Follicle-Stimulating Hormone
Total Employees: 101 - 200 People
Total Annual Revenue: Below US$1 Million
Year Established: 2001 Verified
Top 3 Markets: North America 16.67% South America 16.67% Eastern Europe 16.67%
Certifications: GMP
Qingdao Kangyuan Pharmaceutical Co., Ltd. was established in Aug., 1995. We are a synthetic & hi...
Qingdao Kangyuan Pharmaceutical Co., Ltd. was established in Aug., 1995. We are a synthetic & high-tech biochemical pharmaceutical enterprise integrating scientific research, manufacturing and marketing. We are the vice-president of Shanghai Biopharmaceutical Committee.

Our products include HCG, HMG, Chondroitin Sulfate, UK, FSH and Sodium Benzoate.

The purified HCG project, with high yield and high titer, uses the urine of pregnant women as raw material. The purified HMG project, with high yield and high titer, uses the urine of amenorrhoea women as raw material, and the purified UK project, with high yield and high titer, uses men's urine as raw material. They have passed the appraisal organized by Qingdao Science Committee, reaching International Leading Level.

In chondroitin sulfate aspect, our company was approved to expand the production area by Shandong Food and Drug Administration, as the designated production enterprise to produce the bulk drug of chondroitin sulfate, and we were approved to produce pharmaceutical grade by Shandong Food and Drug Administration in Jul., 2005. At present the annual output of chondroitin sulfate is more than 30,000 million units, and the one of unit potency is 180-200usp/mg. DS and anti-factor XA conform to USP standards. The monthly production capacity of chondroitin sulfate is more than 30 tons. Our company has been one of the largest enterprises producing chondroitin sulfate bulk drugs.

The quality of our products conforms to USP-31, BP-2003 and CP-2005 standards. All these items have passed GMP test.

As the biological pharmaceutical products of our company are favored by customers in America, Germany, England, the Netherlands, Spain, Italy, Switzerland, India, Japan, Korea, Russia, Egypt and other countries and regions, our products are best-selling and unabated.

Trade Capacity View More >

Trade & Market
Main Markets Total Revenue(%)
North America 16.67%
South America 16.67%
Eastern Europe 16.67%
Southeast Asia 16.67%
Africa 16.67%
Western Europe 16.67%
Export Percentage: 61% - 70%
Email to this supplier